FDA Approves First Next-Generation DNA Sequencing Platforms
This article was originally published in The Pink Sheet Daily
Executive Summary
Illumina’s MiSeqDx instrument and MiSeqDx Universal Kit, granted de novo approval, allow clinicians to “develop and validate sequencing of any part of a patient’s genome,” FDA says.